Comparison of the differences of domestic and foreign pharmacoeconomic research on heart failure medications
- VernacularTitle:国内外心力衰竭治疗药物经济学研究的差异比较
- Author:
Ruijia SHEN
1
;
Xiaoyu YANG
2
;
Defeng SUN
3
;
Weiya LI
2
;
Zhenying ZHAO
2
Author Information
1. Dept. of Pharmacy，Tianjin People’s Hospital/the First Affiliated Hospital of Nankai University，Tianjin 300121，China;School of Pharmacy，Tianjin Medical University，Tianjin 300070，China
2. Dept. of Pharmacy，Tianjin People’s Hospital/the First Affiliated Hospital of Nankai University，Tianjin 300121，China
3. School of Pharmacy，Tianjin Medical University，Tianjin 300070，China
- Publication Type:Journal Article
- Keywords:
heart failure medications;
pharmacoeconomic research;
international experience;
cost-effectiveness analysis;
cost-
- From:
China Pharmacy
2026;37(5):626-632
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide a basis for aligning Chinese pharmacoeconomic research on heart failure （HF） with international standards. METHODS A qualitative comparison o f domestic and global HF pharmacoeconomic studies was conducted across four dimensions： research methods and model application， research perspectives and endpoints， data sources and parameter selection， and policy translation and practical impact. RESULTS & CONCLUSIONS Global studies predominantly utilize long-term dynamic models， societal perspectives， real-world data integration， and directly inform reimbursement decisions. Conversely， domestic research often relies on short-term simplified models， a single healthcare system perspectives， literature-derived data， and individual medicine recommendations. Future domestic studies should transition to long-term dynamic modeling， develop localized disease-specific utility databases via big data， establish reimbursement-linked closed-loop mechanisms， and foster multidisciplinary collaboration to optimize healthcare resource allocation.
